ArticleBMC medical informatics and decision making2026
Phenotype discovery and mortality prediction in sepsis-induced myocardial dysfunction: a deep learning and stratified modeling approach.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Sepsis-induced myocardial dysfunction (SIMD) is a common and heterogeneous complication in patients with sepsis and is associated with increased mortality. This study aimed to identify distinct clinical phenotypes of SIMD using unsupervised deep learning and to develop an optimal short-term survival prediction model based on phenotypic stratification. Data from SIMD patients in the MIMIC-III and MIMIC-IV databases were retrospectively analyzed. An autoencoder was used for feature compression, followed by Uniform Manifold Approximation and Projection (UMAP) and K-means clustering to identify phenotypes, with a novel composite scoring system applied to ensure robust cluster selection. Prognostic differences among phenotypes were evaluated using Kaplan-Meier and Cox regression analyses. XGBoost with SHAP (Shapley Additive Explanations) was used for phenotype prediction and model interpretability. Multi-strategy models (M1-M4) were further constructed to assess the predictive value of phenotypic stratification and determine the optimal modeling strategy for survival prediction. Three clusters (Cluster 0-2) with distinct prognostic profiles were identified. Cluster 2 (high-risk phenotype), characterized by metabolic acidosis and multiorgan dysfunction, showed the highest 90-day mortality (55.1% in the development cohort). SHAP analysis highlighted lactate, bilirubin, coagulation indices, and Glasgow Coma Scale as key drivers of phenotype differentiation. Phenotype-specific modeling (M3) significantly outperformed the global model (M1), achieving a validation AUC of 0.880 and a PR-AUC of 0.863 for Cluster 2. Further feature enhancement in M4 did not yield significant additional benefit, supporting M3 as the optimal modeling strategy. These findings delineate clinically actionable SIMD phenotypes using interpretable unsupervised learning and demonstrate that phenotype-specific modeling markedly improves mortality prediction, particularly for Cluster 2 (high-risk phenotype), underscoring the potential of phenotypic stratification to advance precision critical care in SIMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.